Commentary · 1 Oct 2025
Conference abstractPublished 2 Nov 2017
Interleukin-6-mediated signal transduction in autoimmune disorders
Case Western Reserve University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Interleukin-6 (IL-6) is one of several pro-inflammatory cytokines found at elevated levels in various autoimmune disorders such as rheumatoid arthritis (RA). In that regard, IL-6 was shown to play a prominent role in the pathogenesis and progression of RA. However, in order to establish how IL-6 could be involved in the progression of RA through its capacity to alter the function(s) of articular chondrocytes, we explored several relevant mechanisms by which IL-6 affected human chondrocytes in vitro. We found that incubating the C28/I2 line of immortalized human chondrocytes with recombinant human IL-6 (rhIL-6), the IL-6-like cytokine, rh-oncostatin M or the adipokine, rh-adiponectin caused phosphorylation (i.e. activation) of ERK1/2, p38α MAPK and JNK1/2. We also reported that rhIL-6 activated STAT-1, STAT-3 and STAT-5 without altering total STAT-1, -3 and -5, although STAT-1 was constitutively phosphorylated in another human chondrocyte line, T/C28a2. Matrix metalloproteinase-9 (MMP-9) plays a key role in RA by degrading cartilage extracellular matrix proteins. We found that rhIL-6 increased the synthesis of MMP-9 in the human chondrocyte lines. Of note, production of MMP-9 was inhibited by tocilizumab, a fully humanized monoclonal antibody which neutralizes the interaction of IL-6 with the membrane-bound IL-6 receptor-α/gp130 complex, membrane IL-6R or soluble IL-6 receptor (sIL-6R). Whereas the combination of rhIL-6 and sIL-6R significantly increased MMP-9 compared to sIL-6R, sIL-6R alone inhibited MMP-9 production by C28/I2 chondrocytes when compared to rhIL-6. This latter finding may be germane in the design of a future biological therapy for RA.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 6 Nov 2017
MAP4K3/GLK is a novel therapeutic target for IL-17A-mediated autoimmune diseases
Conference abstract · 2016
Cell surface CD44 of β cell, a mediator of β cell destruction in autoimmune diabetes
Commentary · 3 Mar 2025
Extracellular Vesicle-Mediated Signal Transmission in Neurodegenerative Disorders: A Double-Edged Sword
Commentary · 27 Dec 2024
Scaffold Signaling Proteins: Key Regulators of Cellular Communication and Signal Transduction
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectImmunology & Microbiology
- SubjectSocial Sciences & Humanities
- BylineArticles whose byline prints “Charles J Malemud”
